Abstract
A controversial proposal to have drug companies' “patient compliance” programmes declared legal in France has failed.
Critics described the proposal as a backdoor attempt to introduce into France direct to consumer drug advertising, which is currently banned throughout Europe.
Critics described the proposal as a backdoor attempt to introduce into France direct to consumer drug advertising, which is currently banned throughout Europe.
| Original language | English |
|---|---|
| Pages (from-to) | 279-279 |
| Number of pages | 1 |
| Journal | BMJ (Clinical research ed.) |
| Volume | 334 |
| Issue number | 7588 |
| DOIs | |
| Publication status | Published - 10 Feb 2007 |